Newcastle disease virus vaccine
Commercial- Indications
- Newcastle disease in poultry
Company intelligence / Profile preview
The company markets a portfolio of over forty veterinary vaccines with commercial sales across China and exports to Vietnam, Pakistan, and Egypt. It has recently launched its first canine rabies vaccine commercially in China. Clinical trials have been completed for additional feline and canine products. The company continues to expand into pet/companion animal markets while maintaining a strong presence in livestock health.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhengye Biotechnology Holding Limited.